InspireMD, Inc. (NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, announced Friday that the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard Prime EPS.
CGuard Prime was developed incorporating extensive user feedback and optimizes the deliverability and deployment of the proven CGuard stent. With its proprietary MicroNet mesh, CGuard is designed to reduce both early and late embolic events by trapping debris against the vessel wall, preventing plaque prolapse and embolization that can cause stroke.
"Securing CE Mark certification under the EU MDR is a major milestone that demonstrates InspireMD's commitment to advancing our next generation platforms, regulatory rigor, and execution," said Marvin Slosman, CEO of InspireMD. "This approval clears the path for the commercial launch of CGuard Prime EPS across our current CE marked served markets, taking a pivotal step forward in our growth as a commercial-stage company and further strengthening our leadership in carotid stenting innovation."
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.